Private healthcare in emerging markets : an investor’s perspective (Inglês)

• Data do documento

  2016/06/01

• TIpo de documento

  Boletim

• No. do relatório

  115713

• Nº do volume

  1

• Total Volume(s)

  1

• País

  Mundo,

• Região

  Regiões Mundiais,

• Data de divulgação

  2017/07/21

• Disclosure Status

  Disclosed

• Nome do documento

  Private healthcare in emerging markets : an investor’s perspective

• Palavras-chave

  access to quality care;health sector in particular;demand for health services;access to finance;life science;health service provider;global economic slowdown;public health challenge;healthcare provider;public private collaboration;foreign exchange policy;double bottom line;allocation of fund;pharmaceutical supply chain;private equity investment;cost of treatment;economies of scale;health care delivery system;Complications of Pregnancy;health information system;emerging market economy;public health system;oral cholera vaccine;neglected tropical diseases;availability of vaccine;mass vaccination campaign;continuum of care;physician and patient;impact on health;public health service;health sector markets;bricks and mortar;management of patients;public health impact;private health insurance;access to health-care;private service provider;social health insurance;Private Sector Growth;digital technology;healthcare delivery;heart failure;healthcare sector;river blindness;healthcare costs;strategic partner;clinical care;clinical trial;anchor investor;cancer care;foreign currency;healthcare services;business case;Infectious Disease;healthcare professional;clinic visit;electronic health;medical device;physical location;chronic condition;legacy system;patient records;investee companies;impact investment;advanced economy;debt finance;disease burden;commodity price;security requirement;health care facilities;local financing;political uncertainty;emerging country;affordable finance;lab worker;equipment supplier;funding program;primary healthcare;bicycle traffic;health goal;patient compliance;local bank;free press;business process;healthcare system;capital outflow;Cardiovascular Disease;foreign institution;financial service;aging population;funds target;medical outcomes;medical personnel;asset price;project plan;high debt;risk sharing;medical equipment;export market;productivity gain;global economy;private provider;Investment companies;business model;health investment;management service;essential care;innovative solution;sustainable business;primary care;blended finance;Advisory services;discussion group;health agenda;open debate;international stakeholders;low-income family;clean slate;government funding;infrastructure business;commercial sector;percent change;international standard;core infrastructure;change management;equity return;inpatient service;hospital bed;integrated care;laboratory equipment;Child Mortality;monetary policy;molecular diagnostic;Public Spending;global trade;capital flow;lung disease;bond issue;access agreement;human error;inaccurate result;affordable price;financial resource;fund management;pharmaceutical company;Performance Standards;financial return;social impact;health outcome;global health;maternal death;hepatitis c;Endemic Disease;investment proposal;Learning and Innovation Credit;Preferred Shares;heavy industry;commodity producer;food consumer;cheap oil;economic recovery;medication compliance;hospital admission;remote diagnosis;institutional care;Community Services;laboratory result;Macroeconomic Analysis;care to patient;chronic disease;Mobile Health;care model;Disease Prevention;disposable income;affected country;active participant;gestational diabetes;funding support;regulatory submission;net worth;Antenatal Care;vulnerable woman;humanitarian emergency;parasitic infection;heavy burden;test seek;regulatory approval;telecommunication technology;digital image;disease progression;funding mechanism;target market;prevention including;scarce resource;private law;state budget;rural community;Medical technologies;tech company;outreach program;tertiary treatment;demographic trend;investment opportunities;low-income group;respiratory disease;shift work;community workers;medical technology;medical education;medical cost;global experience;local facility;referral system;sustainable solution;commercial investment;delivery model;lifestyle choice;clinical staff;potential investment;technological innovation

• Exibir mais
• Idioma

  Inglês

• Tópicos históricos

  Tuberculosis, Education, Public Health, Health, Telemedicine,

• Tópicos históricos

  Indústria, Saúde, Nutrição e População,

• Subtópicos históricos

  Health Care Services Industry, Health Information & Communications Technologies, Public Health Promotion, Educational Sciences, Cholera, Tuberculose, Communicable Diseases, Leprosy,

• Unidade proprietária

  Health GP - IFC (GHNDR)

• Version Type

  Final

• Citação da fonte

  /pt/publication/documents-reports/documentlist?src_cit=IFC's health sector newsletter. ">IFC's health sector newsletter. -- no.2, June 2016

• Exibir menos

COMPLETAR RELATÓRIO

Versão oficial do documento (pode conter assinaturas, etc.)

• PDF oficial
• TXT*
• Total Downloads** :
• Download Stats

• *A versão do texto é um OCR incorreto e está incluído unicamente em benefício de usuários com conectividade lenta.